Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative

Steroids

Volumn 71, Issue 7, 2006, Pages 639-646

  Raobaikady, Bindumalini ^a   Parsons, Michael F C ^a   Reed, Michael J ^a   Purohit, Atul ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

7 Methyl ethinylestradiol; 7 Methyl norethisterone; Aromatase; Hormone replacement therapy; Tibolone

Indexed keywords

ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; LETROZOLE; NORETHISTERONE; NORETYNODREL; PHENOL DERIVATIVE; TIBOLONE;

AROMATIZATION; ARTICLE; CANCER CELL; CHORIOCARCINOMA; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; METABOLITE; PRECURSOR; THIN LAYER CHROMATOGRAPHY;

AROMATASE; AROMATASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ETHINYL ESTRADIOL; NITRILES; NORETHINDRONE; NORPREGNENES; TRIAZOLES; TUMOR CELLS, CULTURED;

EID: 33646787774     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.03.006     Document Type: Article

References (38)

1. Modelska K., and Cummings S. Tibolone for postmenopausal women: systematic review of randomised trials. J Clin Endocrinol Metab 87 (2002) 16-23
2. Albertazzi P., Di Micco R., and Zanardi E. Tibolone: a review. Maturitas 30 (1989) 295-305
3. Vos R.M.E., Krebbers S.F.M., Verhoeven C.H.J., and Delbressine L.P.C. The in vivo human metabolism of tibolone. Drug Metab Dispos 30 (2002) 106-112
4. Markiewicz L., and Gurpide E. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD14) and its metabolites in human endometrium. J Steroid Biochem 35 (1990) 535-541
5. DeGooyer M.E., Deckers G.H., Schoonen W.G.E.J., Verheul A.M., and Kloosterboer H.J. Receptor profiling and endocrine interactions of tibolone. Steroids 68 (2003) 21-30
6. Kloosterboer H.J. Intracrinology: the secret of the tissue-specificity of tibolone. J Br Menopause Soc 6 (2000) 23-27
7. Chetrite G., Kloosterboer H.J., and Pasqualini J.R. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res 17 (1997) 135-140
8. Raobaikady B., Day J.M., Purohit A., Potter B.V.L., and Reed M.J. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites. J Steroid Biochem Mol Biol 94 (2005) 229-237
9. Kloosterboer H.J. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76 (2001) 231-238
10. Fotherby K.F., and James F. Metabolism of synthetic steroids. Adv Steroid Biochem Pharmacol 3 (1972) 67-165
11. Breuer H., Dardenne U., and Nocke W. Ausscheidung von 17-ketosteroiden, 17-ketogen steroiden und oestrogen beim mencschen und gaben von 17-athynyl-19-nor-testosterone-estern. Acta Endocr 33 (1960) 10-26
12. Townsley J.D., and Brodie H.J. A new placental metabolite of oestr-4-ene-3,17-dione: a possible source of error in oestrogen estimation. Biochem J 101 (1966) 25c-27c
13. Townsley J.D., and Brodie H.J. Mechanism of oestrogen biosynthesis IV Ovarian metabolism of estr-4-ene-3,17-dione. Biochim Biophys Acta 144 (1976) 440-445
14. Sisenwine S.F., Liu A.l., Kimmel H.B., and Ruelius H.W. Phenolic metabolites of dl-norgestrel: a method for the removal of 1-hydroxylated metabolites, potential sources of phenolic metabolites. Acta Endocr 76 (1964) 789-800
15. Barbieri R.L., Petro Z., Canick J.A., and Ryan K.J. Aromatization of norethisterone to ethinylestradiol by human placental microsomes. J Clin Endocrinol Metab 57 (1983) 299-303
16. Urabe M., Yamamoto T., Yoshiji S., Honjo H., and Okada H. Aromatization of norethisterone to ethynyestradiol in human adult liver. Steroids 50 (1987) 607-608
17. Reed M.J., Ross M.S., Lai L.C., Ghilchik M.W., and James V.H.T. In vivo conversion of norethisterone to ethinyloestradiol in perimenopausal women. J Steroid Biochem Mol Biol 37 (1990) 301-303
18. Kuhnz W., Heuner A., Humpel M., Seifert W., and Michaelis K. In vivo conversion of norethisterone and norethisterone acetate to ethinyestradiol in postmenopausal women. Contraception 56 (1997) 379-385
19. Grodin J.M., Siiteri P.K., and MacDonald P.C. Souce of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36 (1973) 207-214
20. Wiegratz I., Sanger N., and Kuhl H. Formation of 7α-methyl-ethinyl estradiol during treatment with tibolone. Menopause 9 (2002) 293-295
21. Bodine P.V.N., Harris H.A., Lyttle C.R., and Komm B.S. Estrogenic effects of 7α-methyl-17α-ethynylestradiol: a new discovered tibolone metabolite. Steroids 67 (2002) 681-686
22. Thompson R.M., and Horning E.C. Aromatization of the A-ring of norethynodrel, a steroidal oral contraceptive, during trimethylsiylation. Steroids Lipid Res 4 (1973) 135-142
23. De Gooyer M.E., Oppers-Tiemissen H.M., Leysen D., Verheul H.A.M., and Kloosterboer H.J. Tibolone is not converted by human aromatase to 17α-methyl-17α-ethynylestradiol (7α-MEE): analyses with sensitive bioassays for estrogens and androgens and LC-MS/MS. Steroids 68 (2003) 235-243
24. Jones M.E.E., Reutens A.T., Boon W.C., Erderveen A.G., Kloosterboer H., and Simpson E.R. The aromatase knockout (ArKO) mouse as a modle to study the oestrogenic action of tibolone. Proceedings of 46th meeting of Endocrine Society of Australia (2003) 112
25. Bahn R.S., Worsham A., Speeg K.V., Ascoli M., and Rabin D. Characterisation of steroid production in cultured human choriocarcinoma cells. J Clin Endocrinol Metab 52 (1981) 447-450
26. Frost P.G., Reed M.J., and James V.H.T. The aromatization of androstenedione by human adipose tissue and liver tissue. J Steroid Biochem 13 (1980) 1427-1431
27. Sandker G.W., Vos R.M.E., Delbressine L.P.C., Sloff M.J.H., Meijer D.K.F., and Groothuis G.M.M. Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica 24 (1994) 143-155
28. Verhoeven C.H.J., Vos R.M.E., and Delbressine L.P.C. The in vivo metabolism of tibolone in animal species. Eur J Metabol Pharmacokin 27 (2002) 1-10
29. Kuhnz W., Sostarek D., Gansau C., Louton T., and Mahler M. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinylestradiol and free and total testosterone levels in serum. Am J Obstet Gynecol 165 (1991) 596-602
30. Doren M., Rubig A., Coelingh B.H.J., and Holzgreve W. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate therapy. Fert Steril 75 (2001) 554-559
31. Million Women Study Collaborators. Breast Cancer and hormone-replacement therapy. Lancet 362 (2003) 419-427
32. Million Women Study Collaborators. Endometrial cancer and hormone-replacment therapy in the million women study. Lancet 365 (2005) 1543-1551
33. Tang B., Markiewicz L., Kloosterboer H.J., and Gurpide E. Human endometrial 3β-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestogenic ratios of a steroidal drug (Org 14). J Steorid Biochem Mol Biol 45 (1993) 345-351
34. Huber J., Palacios S., Berglund L., et al. The effect of tibolone compared with conjugated equine oestrogens continuously combined with medroxyprogesterone acetate on bleeding rates. Br J Obstet Gynaecol 109 (2002) 886-893
35. Volker W., Coelingh B.H.J.T., and Helmond F.A. Effects of tibolone on endometrium. Climacteric 4 (2001) 203-208
36. Hammar M., Christau S., Nathorst-Boos J., Rud T., and Garre K. A double-blind randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 105 (1998) 904-911
37. Kloosterboer H.J., Schoonen W.G., Deckers G., and Klijn J.G. Effects of progestogens and Org OD14 in in vitro and in vivo tumor models. J Steroid Biochem Molec Biol 49 (1994) 311-318
38. Helmond F.A., and Kloosterboer H.J. Safety and tolerability profile of livial. In: Genazzani A.R. (Ed). Hormone replacement therapy and cancer. The current status of research and practise (2002), The Parthenon Publishing Group, BocaRaton